SCHEMBL248816

SCHEMBL248816

O=C(Cl)Oc1ccccc1C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.66
ALDH1A1 P00352 10/20 0.66
HSD17B10 Q99714 7/20 0.66
HPGD P15428 6/20 0.66
ESR1 P03372 2/20 0.66
HMGB1 P09429 2/20 0.66
NAPRT Q6XQN6 2/20 0.66
ITGB3 P05106 1/20 0.66
ITGA2B P08514 1/20 0.66
TSHR P16473 1/20 0.66
GGT1 P19440 1/20 0.66
PTGS1 P23219 1/20 0.66
PTGS2 P35354 1/20 0.66
BLM P54132 1/20 0.66
TDP1 Q9NUW8 1/20 0.66
MAPT P10636 1/20 0.63
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
USP2 O75604 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1721235 0.83 KDM4E (0.78) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL766761 0.83 KDM4E (0.70) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL8530334 0.82 ELANE (0.63) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL5696260 0.82 SERPINE1 (0.43) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL30524282 0.82 SERPINE1 (0.43) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL11208120 0.81 KDM4E (0.79) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL13189200 0.79 KDM4E (0.66) KDM4EALDH1A1HSD17B10HPGDESR1
SCHEMBL1810676 0.79 KDM4E (0.66) KDM4EALDH1A1HSD17B10HPGDESR1
Aspirin SCHEMBL1331740 0.79 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDESR1
Aspirin SCHEMBL7580 0.79 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417514-A2 Method for preparing reactively terminated polycarbonates GENERAL ELECTRIC COMPANY (US) 1991-03-20 EP claimed
JP-3152126-A None JP disclosed
EP-2588107-A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET Takeda Pharmaceutical Company Limited (JP) 2013-05-08 EP disclosed
WO-2012003338-A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-01-05 WO disclosed
EP-2313407-A1 cMET INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2011-04-27 EP disclosed
WO-2010019899-A1 cMET INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed
JP-H03152126-A PRODUCTION OF REACTIVELY TERMINATED POLYCARBONATE GENERAL ELECTRIC CO <GE> 1991-06-28 JP disclosed
EP-0417511-A2 Method for preparing block polyphenylene ether-polycarbonates GENERAL ELECTRIC COMPANY (US) 1991-03-20 EP disclosed
EP-0417514-A2 Method for preparing reactively terminated polycarbonates GENERAL ELECTRIC COMPANY (US) 1991-03-20 EP disclosed
EP-0417514-A2 Method for preparing reactively terminated polycarbonates GENERAL ELECTRIC COMPANY (US) 1991-03-20 EP disclosed
US-4973628-A MELT PROCESSABILITY, SALICYLATE ENDCAPPED POLYCARBONATE, TRANSESTERIFICATION GENERAL ELECTRIC COMPANY (US) 1990-11-27 US disclosed